611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
New Hope Against Diseases Marked by Progressive Scarring of Lung TissueAHA News: What Heart and Stroke Patients Should Know About COVID-19 VaccinesCOVID Pandemic Shortened U.S. Life Expectancy by More Than a YearShorter COVID Quarantine for College Athletes a Good Idea, Study FindsWhat Happened to the Flu This Year?3 Steps Could Nearly Eliminate COVID Infections on College Campuses: StudyPharmacy Chains Ready to Supply COVID-19 Vaccines to AmericansI've Already Had COVID-19, Do I Need the Vaccine?What Will COVID-19 Look Like Years From Now?First Computer Model of Entire COVID Virus Will Aid ResearchStopping Common Heart Meds Could Be Risky for Kidney PatientsU.S. COVID Vaccine Rollout Nears 1 Million Doses Per DayJohnson & Johnson's One-Dose COVID Vaccine Promising in Early TrialLockdowns' Benefits for Air Quality Weren't as Big as Thought: StudyPeople's 'Microbiomes' Might Influence COVID-19 Severity: StudyNew Insights Into How COVID-19 Damages the BrainCollege Campuses Are COVID 'Superspreaders,' Study FindsStuck at Home, Suffering With COVID? Experts Offer Guidance on CareCOVID Daily Death Toll Sets New U.S. Record, Soars Past 4,400AHA News: Registries Could Offer Insight Into COVID-19's Impact on College Athletes' HeartsResearch Reveals Why COVID Pneumonia Is More DeadlyPandemic Is Tied to Big Rise in U.S. Heart DeathsCommon Diabetes Meds Tied to Serious COVID-19 ComplicationPlant-Based Diet Brings Better 'Microbiome,' Healthier LifeAnswering Your Qs on the New COVID VaccinesEven Mild Cases of COVID Can Leave 'Long-Haul' Illness, Study ShowsCommon Blood Pressure Meds Won't Up Risks for COVID Patients: StudySix Months Later, Most Wuhan COVID Survivors Still Have Health IssuesHealth Officials Work to Speed Up U.S. COVID Vaccine RolloutAllergists' Group Offers Guidelines on COVID-19 VaccinesFacebook Posts Big Drivers in Vaccine Resistance, Study FindsBlack Patients at Higher Risk When Type 1 Diabetes and COVID CombineBiden Says He Will Release All Vaccine Doses After Taking Office'Pandemic Fatigue' Setting in? Here's How to Stay Safe and StrongCould High Pollen Levels Trigger Pelvic Pain?Record Number of COVID Cases, Deaths Reported in U.S.COVID Survivors' Plasma Might Prevent Worsening Illness in Older Patients: StudyAHA News: Dr. Dre Recovering From a Brain Aneurysm. What Is That?Certain Antibiotics Linked With Upped Risk for Deadly Aortic AneurysmsDeath Risk Nearly Doubles When COVID Strikes People With Heart FailureMore Infectious COVID Variant Likely Widespread in the U.S., Experts SayRed Cross Issues Call for More Blood Plasma to Treat COVID PatientsPediatricians' Group Says School Is Priority, With Proper Safety MeasuresMoves, Evictions Often Trigger Harmful Breaks in Health Care: StudyAllergic Reactions to COVID Vaccines Are Rare, Resolved on Site: CDCSurvey Shows Mental Woes Spiked in U.S. Pandemic's First MonthsYour 'To-Do' List as You Await a COVID VaccineSome Americans Can't Access Telemedicine, Study ShowsU.S. COVID Hospitalizations Reach Record High as California Hospitals Run Out of OxygenVaccine Rollout Could Have Americans Back to Normalcy by Summer, Expert Says
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Top FDA Officials Say Two Full Doses of COVID Vaccines a Must

HealthDay News
by By Ernie Mundell and Robin Foster HealthDay Reporters
Updated: Jan 5th 2021

new article illustration

TUESDAY, Jan. 5, 2021 (HealthDay News) -- Two top officials at the U.S. Food and Drug Administration said Monday that any American who gets the Moderna or Pfizer coronavirus vaccines must get two full doses, despite international debate on possible ways to stretch vaccine supply.

"We have been following the discussions and news reports about reducing the number of doses, extending the length of time between doses, changing the dose [half-dose], or mixing and matching vaccines in order to immunize more people against COVID-19," FDA Commissioner Dr. Stephen Hahn and Dr. Peter Marks, who heads FDA's vaccine division, said in an agency statement.

"These are all reasonable questions to consider and evaluate in clinical trials. However, at this time, suggesting changes to the FDA-authorized dosing or schedules of these vaccines is premature and not rooted solidly in the available evidence," they added.

On Sunday, Operation Warp Speed's top adviser, Moncef Slaoui, told CNN that the FDA would consider giving half-doses of Moderna's vaccine to people aged 18 to 55 -- which could deliver the vaccine to twice as many people in that age group.

Slaoui said earlier data showed that the vaccine appeared to rouse similar antibody responses among volunteers under age 55 who received either the full 100-microgram dose or a half dose.

But Marks and Hahn said these preliminary findings covered only a few people who were not followed long enough to see if their immune responses held up over time.

"What we have seen is that the data in the firms' submissions regarding the first dose is commonly being misinterpreted. In the phase 3 trials, 98% of participants in the Pfizer-BioNTech trial and 92% of participants in the Moderna trial received two doses of the vaccine at either a three- or four-week interval, respectively," they said in their statement. "Those participants who did not receive two vaccine doses at either a three-or four-week interval were generally only followed for a short period of time."

Changing the dosage could also hamper the U.S. vaccine effort just as the public is starting to trust the program, Dr. Anthony Fauci told The New York Times.

"One of the dangers of making a change in midstream is that it could confuse the public," he explained.

He also suggested that changing the vaccine dosage was "the right answer to the wrong question. At the present time, we are not dealing with a shortage of doses -- we are dealing with the need to increase our efficiency in getting people vaccinated," he said.

In the U.K., where England and Scotland have entered a third national lockdown as officials battle a more contagious variant of coronavirus, officials have said they will allow more than 21 days between doses of Pfizer's vaccines and would consider allowing people to get vaccinated with two different vaccines.

But Hahn and Marks rejected those policies for the United States.

"The available data continue to support the use of two specified doses of each authorized vaccine at specified intervals," they wrote. It's understandable that people may want to stretch the vaccine supply, but it's not safe to do so, they added.

"If people do not truly know how protective a vaccine is, there is the potential for harm because they may assume that they are fully protected when they are not, and accordingly, alter their behavior to take unnecessary risks," they explained.

Dr. Paul Offit, an infectious disease specialist at the University of Pennsylvania, told CNN that he thought halving vaccine doses was a bad idea.

"There's no data on efficacy of a half dose. If you use a half dose, you're just making it up. You're just hoping that you're right," said Offit, a member of the FDA's Vaccines and Related Biological Products Advisory Committee. "Why would you dare to make up something when you don't know whether or not it works?"

New coronavirus variant now spotted in 4 U.S. States

On Monday, New York joined Florida, California and Colorado as states with a known case of the new and more contagious variant of the coronavirus.

Experts believe the new variant is probably already spreading elsewhere in the United States.

"The virus is becoming more fit, and we're like a deer in the headlights," Dr. Eric Topol, head of Scripps Research Translational Institute, told the Associated Press.

Topol said that the United States does less genetic sequencing of the virus to discover variants than other nations, and thus was probably slow to detect this new mutation.

No evidence has been found that this variant is more deadly or causes more severe illness, and scientists are saying that the vaccines will work against it. But a faster-spreading virus could swamp hospitals with seriously ill patients.

Researchers estimate the variant is 50% to 70% more contagious, Dr. Eric France, Colorado's chief medical officer, told the AP.

"Instead of only making two or three other people sick, you might actually spread it to four or five people," France said. "That means we'll have more cases in our communities. Those number of cases will rise quickly and, of course, with more cases come more hospitalizations."

The rapid spread of the new variant within Britain has triggered a third national lockdown there, with many countries banning or restricting flights from the United Kingdom.

A global scourge

By Tuesday, the U.S. coronavirus case count passed 20.8 million while the death toll passed 353,700, according to a Times tally. On Tuesday, the top five states for coronavirus infections were: California with over 2.4 million cases; Texas with more than 1.8 million cases; Florida with over 1.3 million cases; New York with over 1 million cases; and Illinois with more than 987,000 cases.

Curbing the spread of the coronavirus in the rest of the world remains challenging.

In India, the coronavirus case count was over 10.3 million on Tuesday, a Johns Hopkins University tally showed. Brazil had over 7.7 million cases and more than 196,500 deaths as of Tuesday, the Hopkins tally showed.

Worldwide, the number of reported infections passed 85.7 million on Tuesday, with more than 1.8 million deaths recorded, according to the Hopkins tally.

More information

The U.S. Centers for Disease Control and Prevention has more on the new coronavirus.

SOURCES: CNN; New York Times; Associated Press